HealthyDirect · Growth
Baroda BNP Paribas Health and Wellness Fund
Baroda BNP Paribas Mutual FundEquity Scheme - Sectoral/ Thematic1.2 years
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
- NAV
- 10.8138
- 15 Sept 2026
- 1Y
- +10.2%
- Trailing CAGR
- AUM
- ₹507.42 Cr
- 31 Aug 2026
- Volatility
- Medium
- 11.4% annualized
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+10.2%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+6.6%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+18.4%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +6.6%
- Calendar-day CAGR
- Excess 1Y
- +4.1%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
Drawdown
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 12 days
- 14 recovered episodes
- Longest recovery
- 110 days
- Trough to prior peak
- Current spell
- 15 days
- Days below latest peak
- Time below peak
- +90%
- NAV observations
30 Jul 2025 – 19 May 2026
Trough 29 Jan 2026 · recovered in 110 days
-11.1%
21 May 2026 – 22 Jun 2026
Trough 2 Jun 2026 · recovered in 20 days
-3.0%
31 Aug 2026 – open
Trough 15 Sept 2026 · not recovered
-2.8%
21 Jul 2026 – 29 Jul 2026
Trough 24 Jul 2026 · recovered in 5 days
-2.1%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
45
Vs category
76
Consistency
100
Risk-adjusted
33
Drawdown
72
Mean
65
Portfolio
31 Aug 2026 · 35 holdings · top 10 are 59.8%.
- Top 5
- 37.2%
- Top 10
- 59.8%
- Largest holding
- 9.0%
- Effective holdings
- 21.2
Sun Pharmaceutical Industries Ltd
Healthcare
9.0%
Divi's Laboratories Ltd
Healthcare
8.0%
Torrent Pharmaceuticals Ltd
Healthcare
8.0%
Ipca Laboratories Ltd
Healthcare
6.2%
Lupin Ltd
Healthcare
6.0%
Decision
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Healthy
Engine status
Healthy
Doing its job
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 1-year windows.
- Peak-to-trough drawdown has stayed shallower than 15%.
Worth investigating
Same-category peers with enough history to inspect beside this fund.
Aditya Birla Sun Life Business Cycle Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- +5.9%
- 3Y
- +11.6%
- Vol
- 13.8%
- Max DD
- -17.8%
- Sharpe
- 0.48
- 3Y win
- +7%
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Aditya Birla Sun Life Commodity Equities Fund - Global Agri Plan
Aditya Birla Sun Life Mutual Fund
- 1Y
- -2.5%
- 3Y
- +20.3%
- Vol
- 16.8%
- Max DD
- -42.2%
- Sharpe
- 0.20
- 3Y win
- n/a
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Aditya Birla Sun Life Infrastructure Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- +10.4%
- 3Y
- +15.8%
- Vol
- 18.5%
- Max DD
- -53.5%
- Sharpe
- 0.60
- 3Y win
- +66%
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Aditya Birla Sun Life Transportation and Logistics Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- +13.3%
- 3Y
- n/a
- Vol
- 18.1%
- Max DD
- -28.2%
- Sharpe
- 0.91
- 3Y win
- n/a
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Baroda BNP Paribas Energy Opportunities Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- +0.7%
- 3Y
- n/a
- Vol
- 13.8%
- Max DD
- -9.7%
- Sharpe
- 0.33
- 3Y win
- n/a
- Shallower drawdown
Caveat: Higher volatility · Lower trailing returns